FDA
-
-
-
-
-
-
-
MannKind develops dry powder inhaler for pulmonary hypertension treatment
-
-
-
-
-
-
-
United Therapeutics publishes positive TETON-2 results in NEJM
-
-
-
-
-
-
-
ReAlta Life Sciences appoints Jonathan Rigby to board of directors
-
-
-
-
-
-
-
MannKind expands United Therapeutics partnership for second inhaled therapy
-
-
-
-
-
-
-
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
-
-
-
-
-
-
-
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
-
-
-
-
-
-
-
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
-
324,690 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

